Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2026-03-01 @ 9:45 AM
Study NCT ID:
NCT03654768
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-18
First Post:
2018-08-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
Sponsor:
SWOG Cancer Research Network
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | View |
Keywords: